Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC381949 | PMC |
Rev Mal Respir
June 2015
Département de pédiatrie, centre de ressources et de compétence pour la mucoviscidose pédiatrique, centre d'investigation clinique, hôpital Pellegrin-Enfants, CHU de Bordeaux, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France. Electronic address:
Aim: To propose a formalized consensus agreement regarding the prescription of azithromycin in cystic fibrosis (CF).
Material And Methods: Application of the Delphi method in 5 thematic fields: indications, contra-indications, dosage, precautions for use and treatment follow-up.
Results: Thirty identified French CF centers participated in the process on 49 (61%), which comprised 3 rounds.
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol
January 1976
The authors present six years experience in connection with the diagnosis and the medical assistance of non-tuberculous broncho-pneumopathies in an anti-tuberculous dispensary. The data presented include 3600 cases with various diseases of which acute pneumopathies represent 11%, chronic bronchitis 14%, and broncho-pulmonary suppurations 9%. It is estimated that such an office of pneumological consultations within an anti-tuberculous dispensary is efficient and can, in the majority of the cases, make a correct diagnosis and provide corresponding dispensarization.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!